Riskpilot← Back to searchSign inGet full accessTudorkliniken AB
ABActiveOrg 5567292981Axel Olsons Gata 4 BMedical specialists activities · NACE 8622Est. 200720-49 employees
Revenue 2024
SEK 42,9M
0% vs 2023
EBITDA margin
5.5%
+5% vs 2023
Equity ratio
22.0%
Financial strength
Net profit 2024
SEK 510K
+71% vs 2023
| Revenue | SEK 42,9M | +0% |
| EBITDA | SEK 2,4M | +5% |
| Net profit | SEK 510K | +71% |
| Total assets | SEK 8,5M | +2% |
| Equity | SEK 1,9M | +37% |
| Employees | — | — |
Legal name
Tudorkliniken AB
Org number
5567292981
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 maj 2007
Share capital
SEK 100 000
Employees
20-49
VAT registered
No
Audit selected
No
Last report
2024-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Aktiebolagets verksamhet ska vara att bedriva hälso- och sjukvård jämte därmed förenlig verksamhet.
Address
Axel Olsons Gata 4 B
Phone
+4635121530
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 43 800 | 45 873 | 44 987 | 42 898 | 42 948 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 912 | 450 | −160 | 2 260 | 2 368 |
| Depreciation & amort. | −354 | −376 | −383 | −411 | −408 |
| EBIT | 1 558 | 74 | −543 | 1 849 | 1 960 |
| Net financials | −28 | −33 | −53 | −12 | 39 |
| Profit before tax | 273 | 940 | 24 | 388 | 645 |
| Tax | −77 | −223 | −19 | −90 | −135 |
| Net profit | 196 | 717 | 5 | 298 | 510 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 6 832 | 6 934 | 8 838 | 8 314 | 8 515 |
| Equity | 347 | 1 064 | 1 070 | 1 367 | 1 877 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 484 | 5 869 | 7 769 | 6 801 | 6 639 |
| Total debt | 6 484 | 5 869 | 7 769 | 6 801 | 6 639 |
EBITDA margin
5.5%
This company
15.8%
Market median
-65% vs market
20202024
Equity ratio
22.0%
This company
38.2%
Market median
-42% vs market
20202024
Return on equity
27.2%
This company
18.4%
Market median
+48% vs market
20202024
Net profit margin
1.2%
This company
8.1%
Market median
-85% vs market
20202024
Asset turnover
5.04×
This company
1.12×
Market median
+350% vs market
20202024
Debt / equity
3.54×
This company
0.62×
Market median
-471% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SA Chief Auditor | Chief Auditor | 2025 |
MO External Signatory | External Signatory | 2025 |
JL Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
MS Audit | Audit | 2020 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Deputy Board Member | 2020 – 2025 | |
| Board of Directors | 2020 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tudor Kvinnoklinik AB
Tudorkliniken AB Board members of Tudorkliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Stefan Svensson | Audit | 0 companies |
| Sara Andrea Westin Asp | Chief Auditor | 0 companies |
| Mats Olof Sin Keun Wessing | External Signatory | 0 companies |
| Jennie Lilian Wijk | Chief Executive Officer | 0 companies |
| Daniela Dobrescu | Deputy Board Member | 0 companies |
| Aristide Tudor Dobrescu | Board of Directors | 0 companies |
| Sofia Elisabet Ljungmark | Deputy Board Member | 0 companies |
| Andreas Barbu Aristide Dobrescu | Deputy Board Member | 0 companies |
| Karl-Johan Seth Nordlöw Sturesson | Board of Directors | 0 companies |